Magyar Telekom Improves 2014 Ebitda View as 2Q Beats Expectations
Magyar Telekom Can't Commit to Resuming Dividend on 2014 Earnings -CFO
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
UPDATE: Want to buy some air? Some cities have plenty to sell
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands
This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...